Enrique
Quintero Carrión
Investigador en el periodo 1998-2024
Hospital Clínico Universitario Lozano Blesa
Zaragoza, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico Universitario Lozano Blesa (34)
2024
-
CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions
Gastric Cancer, Vol. 27, Núm. 4, pp. 747-759
-
Development and validation of a faecal immunochemical test-based model in the work-up of patients with iron deficiency anaemia
Frontiers in Medicine, Vol. 11
2023
-
Fecal occult blood and calprotectin testing to prioritize primary care patients for colonoscopy referral: The advantage study
United European Gastroenterology Journal, Vol. 11, Núm. 7, pp. 692-699
-
Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study)
PLoS Medicine, Vol. 20, Núm. 10
2022
-
Predictive Value of Genetic Risk Scores in the Development of Colorectal Adenomas
Digestive Diseases and Sciences, Vol. 67, Núm. 8, pp. 4049-4058
2021
-
Familial Colorectal Cancer and Genetic Susceptibility: Colorectal Risk Variants in First-Degree Relatives of Patients With Colorectal Cancer
Clinical and translational gastroenterology, Vol. 12, Núm. 2, pp. e00301
2020
-
Retrospective cohort study: Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test
World Journal of Gastroenterology, Vol. 26, Núm. 1, pp. 70-85
-
Validation of miR-1228-3p as housekeeping for microRNA analysis in liquid biopsies from colorectal cancer patients
Biomolecules, Vol. 10, Núm. 1
-
Variation in Colonoscopy Performance Measures According to Procedure Indication
Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 5, pp. 1216-1223.e2
2019
-
Genetic susceptibility in the development of colorectal adenomas according to family history of colorectal cancer
International Journal of Cancer, Vol. 144, Núm. 3, pp. 489-502
-
Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer
Clinical and translational gastroenterology, Vol. 10, Núm. 1, pp. e00003
2018
-
Detection of serrated lesions in proximal colon by simulated sigmoidoscopy vs faecal immunochemical testing in a multicentre, pragmatic, randomised controlled trial
United European Gastroenterology Journal, Vol. 6, Núm. 10, pp. 1527-1537
-
Plasma miRNAs signature validation for early detection of colorectal cancer
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. v106
2017
-
Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs
United European Gastroenterology Journal, Vol. 5, Núm. 2, pp. 255-260
-
Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype
Oncotarget, Vol. 8, Núm. 22, pp. 35848-35862
-
The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients
International Journal of Cancer, Vol. 140, Núm. 10, pp. 2201-2211
2016
-
Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients
BMC Medicine, Vol. 14, Núm. 1
-
Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study
PLoS Medicine, Vol. 13, Núm. 5
2015
-
Association of PSCA rs2294008 gene variants with poor prognosis and increased susceptibility to gastric cancer and decreased risk of duodenal ulcer disease
International Journal of Cancer, Vol. 137, Núm. 6, pp. 1362-1373
2014
-
Rate of Detection of Advanced Neoplasms in Proximal Colon by Simulated Sigmoidoscopy vs Fecal Immunochemical Tests
Clinical Gastroenterology and Hepatology, Vol. 12, Núm. 10, pp. 1708-1716.e4